comparemela.com
Home
Live Updates
Potential Label Restrictions Loom For Alnylam's Patisiran De
Potential Label Restrictions Loom For Alnylam's Patisiran De
Potential Label Restrictions Loom For Alnylam's Patisiran Despite Approval Prospects - Alnylam Pharmaceuticals (NASDAQ:ALNY)
On Wednesday, an FDA advisory committee voted 9-3 in favor of Alnylam Pharmaceuticals Inc's (NASDAQ: ALNY) patisiran.
Related Keywords
,
Renal Drugs Advisory Committee ,
Alnylam Pharmaceuticals Inc ,
Prescription Drug User Fee ,
William Blair ,
Reiterates Neutral ,